The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer

OBJECTIVE: Homologous recombination (HR)-proficient ovarian tumors have poorer clinical outcomes and show resistance to poly ADP ribose polymerase inhibitors (PARPi). A subset of HR-proficient ovarian tumors show amplification in bromodomain and extra-terminal (BET) genes such as BRD4. We aimed to t...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Gynecol Oncol
Päätekijät: Wilson, Andrew J., Stubbs, Matthew, Liu, Phillip, Ruggeri, Bruce, Khabele, Dineo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2018
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5986599/
https://ncbi.nlm.nih.gov/pubmed/29567272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2018.03.049
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia